Hims & Hers Health
HIMS
29.54
+0.07
+0.24%
Hims & Hers Health
US · HIMS
#1813 by market cap
Listed 1970
29.54
+0.07
+0.24%
Live - 5344 symbols - heartbeat 458s ago
· 2026-10-08 07:40
Pre-market
29.16
-1.29%
After-hours
29.59
+0.18%
Overnight
29.43
-0.37%
- Market cap
- 6.89B
- P/E (TTM)i
- -46.16
- P/Bi
- 21.27
- EPSi
- 0.51
- Div yieldi
- 0.00%
- 52W posi
- 31%
Reader sentiment
Are you bullish or bearish on HIMS?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Mixed / stable
- The number of reporting institutions decreased by 1 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 67.54% +0.04pp
- Institutions
- 593 -1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund46.57%
Individual/Insider8.36%
Hedge Fund8.05%
Public Company7.67%
Private Company1.98%
Government Pension Fund1.88%
VC/PE Fund0.62%
Family Office/Trust0.46%
Insurance Company0.27%
Other24.14%
Top holders as of 2026-06-30
BlackRock
12.30% · 28.70M sh
Andrew Dudum
7.12% · 16.61M sh
Vanguard Capital Management, LLC
4.74% · 11.06M sh
Vanguard Portfolio Management, LLC
4.53% · 10.56M sh
State Street Global Advisors
3.49% · 8.15M sh
Morgan Stanley
2.90% · 6.76M sh
Divisadero Street Capital Management, LP
2.58% · 6.01M sh
Geode Capital Management, LLC
2.44% · 5.68M sh
The Goldman Sachs Group, Inc.
1.90% · 4.43M sh
FMR
1.85% · 4.32M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 21 buys · 29 sells
| Name | Role | Stake |
|---|---|---|
| Andrew Dudum | Chairperson & CEO | 7.12% |
| Melissa Baird | Chief Operating Officer | 0.35% |
| Mike Chi | Chief Marketing Officer | 0.20% |
| Soleil Boughton | Chief Legal Officer | 0.13% |
| Oluyemi Okupe | Chief Financial Officer | 0.10% |
| David Wells | Lead Independent Director | 0.10% |
| Patrick Carroll | Chief Medical Officer, Member of Medical Advisory Board & Director | 0.08% |
| Mohamed ElShenawy | Chief Technology Officer | 0.08% |
| Christopher Payne | Director | 0.06% |
| Andrea Perez Garcia | Independent Director | 0.04% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-30 | Oluyemi Okupe | Chief Financial Officer | Automatic Disposition | -2,000 | $29.70 |
| 2026-09-29 | Soleil Boughton | Chief Legal Officer | Automatic Disposition | -3,461 | $29.17 |
| 2026-09-21 | Oluyemi Okupe | Chief Financial Officer | Automatic Disposition | -15,277 | $29.95 |
| 2026-09-21 | Oluyemi Okupe | Chief Financial Officer | Derivative Exercise and Sale | -14,000 | $5.01–29.95 |
| 2026-09-16 | Oluyemi Okupe | Chief Financial Officer | Automatic Disposition | -12,313 | $28.82 |
| 2026-09-15 | Soleil Boughton | Chief Legal Officer | Automatic Disposition | -6,236 | $27.86 |
| 2026-09-14 | Mike Chi | Chief Marketing Officer | Automatic Disposition | -14,027 | $28.39 |
| 2026-09-14 | Mohamed ElShenawy | Chief Technology Officer | Automatic Disposition | -7,954 | $28.39 |
| 2026-09-01 | Soleil Boughton | Chief Legal Officer | Automatic Disposition | -3,458 | $28.33 |
| 2026-08-26 | Andrew Dudum | Chairperson & CEO | Other Disposition | -1,440,855 | -- |
| 2026-08-18 | Soleil Boughton | Chief Legal Officer | Automatic Disposition | -25,111 | $27.55 |
| 2026-08-18 | Oluyemi Okupe | Chief Financial Officer | Derivative Exercise and Sale | -4,938 | $5.01–29.99 |
| 2026-08-17 | Deborah Autor | Director | Automatic Disposition | -16,773 | $27.85 |
| 2026-08-16 | Oluyemi Okupe | Chief Financial Officer | Derivative Exercise and Sale | -9,388 | $5.01–27.89 |
| 2026-08-13 | Kare Schultz | Director | Derivative Exercise and Retained | +6,623 | -- |
| 2026-08-13 | David Wells | Lead Independent Director | Derivative Exercise and Retained | +778 | -- |
| 2026-08-13 | Deborah Autor | Director | Derivative Exercise and Sale | -16,147 | $28.15 |
| 2026-08-13 | Deborah Autor | Director | Derivative Exercise and Retained | +16,773 | -- |
| 2026-08-13 | Christopher Payne | Director | Derivative Exercise and Retained | +545 | -- |
| 2026-08-13 | Mike Chi | Chief Marketing Officer | Derivative Exercise and Sale | -47,702 | $28.15 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 07:40:10 · For reference only, not investment advice and not tailored to your situation.